AzTrials
AzTrials

Medically Complex InfantsCIMANCT01659710

Effects of Medical Complexity Using GMA on Lurie Children's In- and Outpatients

An observational study of Medically Complex Infants, run by Raye Ann deRegnier at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to research a new type of test for cerebral palsy that can be performed earlier, at 10-15 weeks of age (after the due date for premature infants). The test involves a standardized video recording of a baby's natural movements for about 10 minutes. Read more about this study

Who is it for?
Ages Up to 5 yearsHealthy volunteers can take part
Conditions the study is for
Medically Complex Infants
How many people
208 participants
Where
1 siteUnited States
Study dates
Jan 2012to 31 Jan 2019
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 5 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Study population: Children's Memorial ICU Patients and Graduates

Who may be able to join

  • Admitted to the NICU/CICU and remain hospitalized at 10-15 weeks postmenstrual age
  • Birth at <28 weeks gestation
  • Birth weight <1000 grams
  • Neurologic risk factors (HIE, abnormal imaging, neonatal seizures, microcephaly)
  • Cardiac surgery during first 3 months of life
  • Severe chronic lung discharge defined as the need for mechanical ventilation at 36 weeks post-menstrual age
  • Discharged home on supplemental oxygen (or if still hospitalized, requiring oxygen at 44 weeks post-menstrual age)

Who cannot join

  • Significant malformations/amputations of the extremities
  • Recovering from a surgical procedure within 4 weeks of the assessment
  • Physiologic instability precluding movement of the hospital bed or peripheral IV lines that might affect movement of an extremity medication for the purpose of ongoing sedation

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Ann & Robert H. Lurie Children's Hospital of Chicago

    Chicago, Illinois, 60611

Other trials in United States

About this study

Official title: Effects of Medical Complexity on the Development of Fidgety Movements and Feasibility of Screening Utilizing the General Movement Assessment for Lurie Children's ICU Patients and Graduates

The purpose of this study is to research a new type of test for cerebral palsy that can be performed earlier, at 10-15 weeks of age (after the due date for premature infants). The test involves a standardized video recording of a baby's natural movements for about 10 minutes. The video recorded movements are evaluated by a special trained observer and also by a computer program. There are some small studies from Europe that suggest that this type of evaluation may be accurate in early diagnosis of cerebral palsy. However, the investigators do not know if this type of evaluation is reliable in large groups of infants, including infants from Children's Memorial Hospital, who tend to be sicker and have more complicated illnesses than many of the European infants. The investigators would therefore like to evaluate whether this type of video recording could be used in the future for early diagnosis of cerebral palsy.

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT01659710
Study groupRoleWhat they receive
Study BabiesStudy video at 50-55 weeks gestational age, motor assessments at 24m (+/- 6 months) and again at 4 years (+/- 1 year).
Control BabiesVideo at 50-55 weeks gestational age, motor assessment at 24 months (+/- 6 months).

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Presence of cerebral palsy

    Measured: 24 months (+/- 6 months) and 4 years (+/- 1 year) of age

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Aug 2012 (estimated)
  2. Study startJan 2012
  3. Primary completion31 Jan 2019
  4. Study completion31 Jan 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
208 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01659710
Sponsor's protocol ID
2012-14808
Acronym
CIMA
Status last verified
Feb 2019
First submitted
5 Aug 2012
Last updated
12 Nov 2024
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Medically Complex Infants, run by Raye Ann deRegnier at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Nov 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Presence of cerebral palsy (time frame: 24 months (+/- 6 months) and 4 years (+/- 1 year) of age). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Nov 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in